Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab (Q58325870)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

title

Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Giacomo Emmi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Gerardo Di Scala

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Silvana Guerriero

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Florenzo Iannone

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Luca Cantarini

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

14

Mauro Galeazzi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

5

Giuseppe Lopalco

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

3

Donato Rigante

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

13

Bruno Frediani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

6

Jurgen Sota

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

16

Gian Marco Tosi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

7

Lorenzo Vannozzi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Antonio Vitale

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Ida Orlando

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Rossella Franceschini

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Marco Capozzoli

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

publication date

18 April 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

1715-1720

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

23 March 2020

cites work

1 reference

12 December 2020

The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center

1 reference

12 December 2020

Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome

1 reference

12 December 2020

Uveitis in Behçet disease: an analysis of 880 patients.

1 reference

12 December 2020

Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

1 reference

12 December 2020

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

1 reference

12 December 2020

Cross-cultural adaptation of the Behçet's Disease Current Activity Form (BDCAF) to Brazilian Portuguese language.

1 reference

12 December 2020

Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome

1 reference

12 December 2020

Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature

1 reference

12 December 2020

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

1 reference

12 December 2020

The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.

1 reference

12 December 2020

Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders

1 reference

12 December 2020

Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.

1 reference

12 December 2020

Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis

1 reference

12 December 2020

Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients

1 reference

12 December 2020

Interleukin-1 Inhibition in Behçet's disease

1 reference

12 December 2020

Behcet's disease: epidemiology, clinical manifestations, and diagnosis.

1 reference

12 December 2020

Adalimumab effectiveness in Behçet's disease: short and long-term data from a multicenter retrospective observational study.

1 reference

12 December 2020

Behcet's syndrome in nonendemic regions

1 reference

12 December 2020

Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study

1 reference

12 December 2020

Behçet's disease: How to diagnose and treat vascular involvement

1 reference

12 December 2020

Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease

1 reference

12 December 2020

Intestinal Behçet and Crohn's disease: two sides of the same coin

1 reference

12 December 2020

Quality of life impairment in Behçet's disease and relationship with disease activity: a prospective study.

1 reference

12 December 2020

Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy

1 reference

12 December 2020

Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study.

1 reference

12 December 2020

One year in review 2017: Behçet's syndrome

1 reference

12 December 2020

Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet's Disease.

1 reference

12 December 2020

Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis.

1 reference

12 December 2020

10.1007/S10067-018-4092-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29671190%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference